Approval · Notice of Compliance 12976 · 2012
NATAZIA: Notice of Compliance 12976
Issued January 30, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12976
- Date
- January 30, 2012
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Oral Contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NATAZIA | 02379112 | Cancelled Pre Market |
Medicinal ingredients
- ESTRADIOL VALERATE 3 MG per TAB
- ESTRADIOL VALERATE 2 MG per TAB
- DIENOGEST 2 MG per TAB
- DIENOGEST 3 MG per TAB
- ESTRADIOL VALERATE 1 MG per TAB